Form 4 for TDOC Teladoc Health, Inc.

Accepted 2023-12-05 00:00:00 ET · period of report 2023-12-01 · accession 0001477449-23-000107 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
DM	2023-12-05	2023-12-01	TDOC	Jensen Claus Torp	Chief INNOVATION Off	M - OptEx	—	+4,850	18.7K	+35%	—
DM	2023-12-05	2023-12-01	TDOC	Jensen Claus Torp	Chief INNOVATION Off	M - OptEx	$0.00	-4,850	12.3K	-28%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2023-12-01	M	A	2,043	—	20,703	D	—	—	(F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
2	Common	Common Stock	2023-12-01	M	A	2,807	—	18,660	D	—	—	(F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
3	Derivative	Restricted Stock Units	2023-12-01	M	D	2,807	$0.00	14,038	D	— · — to —	2,807 Common Stock	(F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. (F2) On March 1, 2022, the reporting person was granted 33,688 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
4	Derivative	Restricted Stock Units	2023-12-01	M	D	2,043	$0.00	12,264	D	— · — to —	2,043 Common Stock	(F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. (F3) On June 1, 2022, the reporting person was granted 24,525 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.